Statins inhibit Toxoplasma gondii multiplication in macrophages in vitro

International Journal of Antimicrobial Agents

Volumn 33, Issue 2, 2009, Pages 185-186

  Cortez, Erika ^a   Stumbo, Ana Carolina ^a   Oliveira, Mariana ^a   Barbosa, Helene S ^b   Carvalho, Lais ^a  

^a IBRAG   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CAROTENOID; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOPRENOID; RETINOID; ROSUVASTATIN; SIMVASTATIN; STEROID; UBIQUINONE;

ANALYSIS OF VARIANCE; BACTERIAL STRAIN; CELL FUNCTION; CELL GROWTH; DRUG INHIBITION; ELECTRON TRANSPORT; HUMAN; IN VITRO STUDY; LETTER; MACROPHAGE; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALS; CELL CYCLE PROTEINS; MACROPHAGES; MICE; NUCLEAR PROTEINS; TOXOPLASMA;

EID: 58149180149     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.07.026     Document Type: Letter

References (7)

1. Cortez E., Stumbo A.C., Saldanha-Gama R., Villela C.G., Barja-Fidalgo C., Rodrigues C.A., et al. Immunolocalization of an osteopontin-like protein in dense granules of Toxoplasma gondii tachyzoites and its association with the parasitophorous vacuole. Micron 39 (2008) 25-31
2. Wiesner J., Reichenberg A., Heinrich S., Schlitzer M., and Jomaa H. The plastid-like organelle of apicomplexan parasites as drug target. Curr Pharm Des 14 (2008) 855-871
3. Moreno S.N., and Li Z.H. Anti-infectives targeting the isoprenoid pathway of Toxoplasma gondii. Expert Opin Ther Targets 12 (2008) 253-263 Erratum in: Expert Opin Ther Targets 2008;12:517
4. Grellier P., Valentin A., Millerioux V., Schrevel J., and Rigomier D. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors lovastatin and simvastatin inhibit in vitro development of Plasmodium falciparum and Babesia divergens in human erythrocytes. Antimicrob Agents Chemother 38 (1994) 1144-1148
5. Buhaescu I., and Izzedine H. Mevalonate pathway: a review of clinical and therapeutical implications. Clin Biochem 40 (2007) 575-584
6. Wang C.Y., Liu P.Y., and Liao J.K. Pleiotropic effects of statin therapy: molecular mechanisms and clinical results. Trends Mol Med 14 (2008) 37-44
7. Santa-Rita R.M., Henriques-Pons A., Barbosa H.S., and de Castro S.L. Effect of the lysophospholipid analogues edelfosine, ilmofosine and miltefosine against Leishmania amazonensis. J Antimicrob Chemother 54 (2004) 704-710